It’s clear that social media has gained widespread popularity amongst the consumer-oriented Fortune 500 crowd. But how about pharmaceutical, biotechnology and devices/diagnostic companies? By and large, they have been reluctant to participate in the social web, instead sticking closely to a Web 1.0 model. That’s the point made in a recent Life Science Leader article by Cliff Mintz:
Indeed, only a handful of life sciences companies have decided to take the social media plunge, claims Jonathan Richman, director of business development at Bridge Worldwide Inc. and author of the popular “Dose of Digital” blog, which tracks social media usage by life sciences and healthcare companies.